PEL-9%-3-11-25-NCDPEL-9%-3-11-25-NCDPEL-9%-3-11-25-NCD

PEL-9%-3-11-25-NCD

No trades
See on Supercharts

9PEL25 analysis



Key facts


Issue date
Nov 3, 2023
Maturity date
Nov 3, 2025
Outstanding amount
‪2.50 B‬INR
Face value
1,000.00INR
Minimum denomination
10,000.00INR
Coupon
9.00% (Fixed)
Yield to maturity
23.55%
Piramal Enterprises Ltd. engages in the business of pharmaceuticals and provision of financial services. It operates through the following segments: Pharmaceuticals Manufacturing and Services, Financial Services, and Healthcare Insights and Analytics. The Pharmaceuticals Manufacturing and Services segment operates through the following divisions: Pharma Solutions, Critical Care, Consumer Products Services and Imaging. The Financial Services segment offers a complete suite of financial products to meet the diverse needs of its customers. The Healthcare Insights and Analytics segment provides indispensable insights to life sciences companies as well as healthcare providers and payers through a variety of high value-added data and analytics, research reports, and knowledge-based services. The company was founded on April 26, 1947 and is headquartered in Mumbai, India.
Go deeper with bond data
Access the most important data for bonds including coupon rates, issue ratings, redemption data and more.